Disease correction by Aav-mediated gene therapy in a new mouse model of mucopolysaccharidosis type Iiid

Carles Roca, Sandra Motas, Sara Marcó, Albert Ribera, Víctor Sánchez, Xavier Sánchez, Joan Bertolin, Xavier León, Jennifer Pérez, Miguel Garcia, Pilar Villacampa, Jesús Ruberte, Anna Pujol, Virginia Haurigot, Fatima Bosch

doi:10.1093/hmg/ddx058

DOI: 10.1093/hmg/ddx058

,

PMID: 28334745

Issn Print: 0964-6906

Publication Date: 2017/04/15

Print

Carles Roca; Sandra Motas; Sara Marcó; Albert Ribera; Víctor Sánchez; Xavier Sánchez; Joan Bertolin; Xavier León; Jennifer Pérez; Miguel Garcia; Pilar Villacampa; Jesús Ruberte; Anna Pujol; Virginia Haurigot; Fatima Bosch

+ Author Information

Author Information: Center of Animal Biotechnology and Gene Therapy


		Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


		Loading Related Articles

Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID

Abstract

Related Topics